Ibrutinib (Imbruvica)
About This Drug
Ibrutinib is used to treat cancer and graft versus host disease (GVHD), a side effect from undergoing an allogeneic stem cell transplant. It is given orally (by mouth).
UPMC Hillman Cancer Center is part of the UPMC family.
Starting Feb. 29, masking is optional but encouraged in UPMC medical facilities and most patient care settings.
Explore this Section
Ibrutinib is used to treat cancer and graft versus host disease (GVHD), a side effect from undergoing an allogeneic stem cell transplant. It is given orally (by mouth).